Humane Genomics Email Format
Biotechnology ResearchNew York, United States2-10 Employees
Humane Genomics is a biotechnology research company based in New York City that focuses on engineering cancer-killing viruses with heightened specificity and efficiency. The organization describes a platform for developing oncolytic viruses, with liver cancer identified as its first therapeutic indication. The team is small and dedicated to advancing this early-stage program. Its target market includes researchers and organizations in cancer therapy development seeking more precise viral therapies. In November 2025, Humane Genomics announced a manufacturing partnership with Genezen Inc. to advance oncolytic virus therapy for pediatric liver cancer.